{"entity":{"type":"insider","cik":"0001555132","url":"/insider/0001555132","json_url":"/insider/0001555132.json","name":"Sohn Catherine A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":18,"first":"2013-08-14","last":"2026-01-08","span_basis":"filed_date"},"name_variants":[{"name":"Sohn Catherine A.","source":"filing","n_filings":18,"first_seen":"2013-08-14","last_seen":"2026-01-08"}],"transactions":[{"id":6149014,"accession":"0001555132-26-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001555132-26-000006","line_url":"/filing/0001555132-26-000006#line-6","is_derivative":false,"issuer_cik":"0001555132","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001555132","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26920.0,"shares_display":"26,920","price_per_share":39.1079,"price_display":"39.11","price_state":"stated","total_value":1052784.668,"total_display":"1,052,784.67","total_whole":"1,052,785","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider"},{"id":6148999,"accession":"0001555132-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555132-26-000006","line_url":"/filing/0001555132-26-000006#line-2","is_derivative":false,"issuer_cik":"0001555132","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001555132","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2493.0,"shares_display":"2,493","price_per_share":38.616,"price_display":"38.62","price_state":"stated","total_value":96269.688,"total_display":"96,269.69","total_whole":"96,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":6108267,"accession":"0001555132-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555132-26-000002","line_url":"/filing/0001555132-26-000002#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.2351,"price_display":"4.24","price_state":"stated","total_value":2117.55,"total_display":"2,117.55","total_whole":"2,118","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":4326845,"accession":"0001104659-25-025032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-025032","line_url":"/filing/0001104659-25-025032#line-1","is_derivative":false,"issuer_cik":"0001326190","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001326190","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.7845,"price_display":"5.78","price_state":"stated","total_value":5784.5,"total_display":"5,784.50","total_whole":"5,785","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":8757727,"accession":"0001765581-23-000092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-23-000092","line_url":"/filing/0001765581-23-000092#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1241.0,"shares_display":"1,241","price_per_share":138.1585,"price_display":"138.16","price_state":"stated","total_value":171454.6985,"total_display":"171,454.70","total_whole":"171,455","shares_owned_after":14868.0,"shares_owned_after_display":"14,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-15","scope":"insider"},{"id":6363593,"accession":"0001765581-22-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-22-000100","line_url":"/filing/0001765581-22-000100#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":152.3229,"price_display":"152.32","price_state":"stated","total_value":165879.6381,"total_display":"165,879.64","total_whole":"165,880","shares_owned_after":13034.0,"shares_owned_after_display":"13,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider"},{"id":4648881,"accession":"0001765581-21-000110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001765581-21-000110","line_url":"/filing/0001765581-21-000110#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306.0,"shares_display":"1,306","price_per_share":147.96,"price_display":"147.96","price_state":"stated","total_value":193235.76,"total_display":"193,235.76","total_whole":"193,236","shares_owned_after":11562.0,"shares_owned_after_display":"11,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider"},{"id":2161029,"accession":"0001765581-20-000109","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001765581-20-000109","line_url":"/filing/0001765581-20-000109","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":153.44,"price_display":"153.44","price_state":"stated","total_value":1918000.0,"total_display":"1,918,000.00","total_whole":"1,918,000","shares_owned_after":10622.0,"shares_owned_after_display":"10,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider","n_lines":2},{"id":2161015,"accession":"0001765581-20-000083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-20-000083","line_url":"/filing/0001765581-20-000083#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":931.0,"shares_display":"931","price_per_share":125.8708,"price_display":"125.87","price_state":"stated","total_value":117185.7148,"total_display":"117,185.71","total_whole":"117,186","shares_owned_after":10622.0,"shares_owned_after_display":"10,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider"},{"id":3301678,"accession":"0001633070-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001633070-20-000002","line_url":"/filing/0001633070-20-000002#line-1","is_derivative":false,"issuer_cik":"0001555132","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001555132","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.87,"price_display":"4.87","price_state":"stated","total_value":4870.0,"total_display":"4,870.00","total_whole":"4,870","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-17","filed_date":"2020-01-21","scope":"insider"},{"id":8717736,"accession":"0001765581-19-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001765581-19-000078","line_url":"/filing/0001765581-19-000078#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":726.0,"shares_display":"726","price_per_share":135.6503,"price_display":"135.65","price_state":"stated","total_value":98482.1178,"total_display":"98,482.12","total_whole":"98,482","shares_owned_after":8848.0,"shares_owned_after_display":"8,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":7795255,"accession":"0001437749-19-000726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-000726","line_url":"/filing/0001437749-19-000726#line-1","is_derivative":false,"issuer_cik":"0001005286","issuer_name":"LANDEC CORP \\CA\\","issuer_ticker":"LNDC","issuer_name_source":null,"issuer_url":"/issuer/0001005286","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.23,"price_display":"11.23","price_state":"stated","total_value":11230.0,"total_display":"11,230.00","total_whole":"11,230","shares_owned_after":25091.0,"shares_owned_after_display":"25,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-11","scope":"insider"},{"id":6375444,"accession":"0001232524-18-000140","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-18-000140","line_url":"/filing/0001232524-18-000140#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":660.0,"shares_display":"660","price_per_share":176.6108,"price_display":"176.61","price_state":"stated","total_value":116563.128,"total_display":"116,563.13","total_whole":"116,563","shares_owned_after":7654.0,"shares_owned_after_display":"7,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-13","scope":"insider"},{"id":6288854,"accession":"0001104659-18-046532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-046532","line_url":"/filing/0001104659-18-046532#line-1","is_derivative":false,"issuer_cik":"0001555132","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001555132","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":23.0,"price_display":"23.00","price_state":"stated","total_value":57500.0,"total_display":"57,500.00","total_whole":"57,500","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-20","filed_date":"2018-07-23","scope":"insider"},{"id":4339155,"accession":"0001232524-17-000152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-17-000152","line_url":"/filing/0001232524-17-000152","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":142.368415407855,"price_display":"142.37","price_state":"stated","total_value":94247.891,"total_display":"94,247.89","total_whole":"94,248","shares_owned_after":6822.0,"shares_owned_after_display":"6,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-14","scope":"insider","n_lines":2},{"id":2074557,"accession":"0001232524-16-000353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-16-000353","line_url":"/filing/0001232524-16-000353#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":633.0,"shares_display":"633","price_per_share":136.45,"price_display":"136.45","price_state":"stated","total_value":86372.85,"total_display":"86,372.85","total_whole":"86,373","shares_owned_after":6116.0,"shares_owned_after_display":"6,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":8721331,"accession":"0001209191-15-065341","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-065341","line_url":"/filing/0001209191-15-065341","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":654.0,"shares_display":"654","price_per_share":177.81835626911314,"price_display":"177.82","price_state":"stated","total_value":116293.205,"total_display":"116,293.20","total_whole":"116,293","shares_owned_after":5394.0,"shares_owned_after_display":"5,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2015-08-11","scope":"insider","n_lines":2},{"id":8721324,"accession":"0001209191-15-065341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-065341","line_url":"/filing/0001209191-15-065341","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":180.00038701622972,"price_display":"180.00","price_state":"stated","total_value":144180.31,"total_display":"144,180.31","total_whole":"144,180","shares_owned_after":6042.0,"shares_owned_after_display":"6,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-11","scope":"insider","n_lines":2},{"id":6832143,"accession":"0001232524-14-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000115","line_url":"/filing/0001232524-14-000115#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1731.0,"shares_display":"1,731","price_per_share":133.15,"price_display":"133.15","price_state":"stated","total_value":230482.65,"total_display":"230,482.65","total_whole":"230,483","shares_owned_after":5529.0,"shares_owned_after_display":"5,529","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-14","scope":"insider"},{"id":5201838,"accession":"0001232524-13-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-13-000092","line_url":"/filing/0001232524-13-000092#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001555132","owner_name":"Sohn Catherine A.","owner_display_name":"Sohn Catherine A.","owner_url":"/insider/0001555132","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":640.0,"shares_display":"640","price_per_share":81.02,"price_display":"81.02","price_state":"stated","total_value":51852.8,"total_display":"51,852.80","total_whole":"51,853","shares_owned_after":5610.0,"shares_owned_after_display":"5,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-14","filed_date":"2013-08-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001842295","name":"Maze Therapeutics, Inc.","url":"/issuer/0001842295","role":"Director","n_filings":1,"first_seen":"2026-01-08","last_seen":"2026-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"Altimmune, Inc.","url":"/issuer/0001326190","role":"Director","n_filings":2,"first_seen":"2025-03-18","last_seen":"2026-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Director","n_filings":12,"first_seen":"2013-08-14","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Director","n_filings":1,"first_seen":"2020-01-21","last_seen":"2020-01-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001005286","name":"LANDEC CORP \\CA\\","url":"/issuer/0001005286","role":"Director","n_filings":1,"first_seen":"2019-01-11","last_seen":"2019-01-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Director","n_filings":1,"first_seen":"2018-07-23","last_seen":"2018-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001555132","retrieved_at":"2026-08-25T18:01:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}